Linked Data API

Show Search Form

Search Results

1128296
star this property registered interest false more like this
star this property date less than 2019-05-22more like thismore than 2019-05-22
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Cannabis: Medical Treatments remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, which countries his Department is engaging with in order to learn from their experiences in getting patients access to medical cannabis. more like this
star this property tabling member constituency Hemel Hempstead more like this
star this property tabling member printed
Sir Mike Penning more like this
star this property uin 257472 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2019-06-10more like thismore than 2019-06-10
star this property answer text <p>In developing its policy on cannabis-based products for medicinal use, the Government looked at approaches taken by other countries to learn from their experience. Broadly two approaches have been taken: to regulate as a medicine (both licenced and unlicensed) as in the United Kingdom or to regulate outside of the medicinal regime as in Canada. In reviewing the available international evidence, the Chief Medical Officer for England and Chief Medical Adviser to the UK Government, looked at evidence reviews from the United States, Ireland, Australia, and the World Health Organization. Departmental officials have also reviewed information from a wide range of other countries and have spoken to the authorities and organisations in Australia, Canada, Denmark, the Netherlands, and the United States (New York).</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 257473 more like this
star this property question first answered
less than 2019-06-10T13:28:33.413Zmore like thismore than 2019-06-10T13:28:33.413Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1528
unstar this property label Biography information for Sir Mike Penning more like this
1128297
star this property registered interest false more like this
star this property date less than 2019-05-22more like thismore than 2019-05-22
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Cannabis: Medical Treatments remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what evidence his Department has reviewed from other countries on the effectiveness of cannabis as a medicine. more like this
star this property tabling member constituency Hemel Hempstead more like this
star this property tabling member printed
Sir Mike Penning more like this
star this property uin 257473 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2019-06-10more like thismore than 2019-06-10
star this property answer text <p>In developing its policy on cannabis-based products for medicinal use, the Government looked at approaches taken by other countries to learn from their experience. Broadly two approaches have been taken: to regulate as a medicine (both licenced and unlicensed) as in the United Kingdom or to regulate outside of the medicinal regime as in Canada. In reviewing the available international evidence, the Chief Medical Officer for England and Chief Medical Adviser to the UK Government, looked at evidence reviews from the United States, Ireland, Australia, and the World Health Organization. Departmental officials have also reviewed information from a wide range of other countries and have spoken to the authorities and organisations in Australia, Canada, Denmark, the Netherlands, and the United States (New York).</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 257472 more like this
star this property question first answered
less than 2019-06-10T13:28:33.447Zmore like thismore than 2019-06-10T13:28:33.447Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1528
unstar this property label Biography information for Sir Mike Penning more like this